Financials
Financial year 2025
integrated DNA technologies from Leuven, company number BE0473291407, closed financial year 2025 with a result of € 7.7 million after tax. For that financial year integrated DNA technologies recorded revenue of € 57.2 million and equity of € 15.4 million. Compared with financial year 2024, the result moved from € 3.6 million to € 7.7 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 15.4 million
▲ 101% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 7.7 million
▲ 112% vs 2024
Profit after tax over the fiscal year.
€ 7.4 million
▼ 9% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 11.8 million.
People and assets in 2025
175.8
▲ 10.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 20 million
▲ 4% vs 2024
€ 114,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 95,895
▲ € 86,757 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6.6 million
▼ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 75 days on average.
€ 2.6 million
▼ 14% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 48,633,625 | € 63,353,035 | € 61,330,342 | € 57,152,038 | ▼ 7% |
| Profit after taxes | € 1,688,038 | € 3,748,683 | € 3,644,673 | € 7,728,517 | ▲ 112% |
| Equity | € 19,278,304 | € 13,026,988 | € 7,671,661 | € 15,400,177 | ▲ 101% |
| Total debts | € 11,264,652 | € 22,887,083 | € 21,931,188 | € 11,986,129 | ▼ 45% |
| Cash | € 10,682,734 | € 12,973,936 | € 8,050,663 | € 7,350,605 | ▼ 9% |
| Retained profit | € 15,640,031 | € 9,388,715 | € 4,033,388 | € 11,761,904 | ▲ 192% |
| Dividend | € 0 | € 10,000,000 | € 9,000,000 | € 0 | ▼ 100% |
| Balance sheet total | € 30,542,957 | € 35,914,071 | € 29,602,849 | € 27,386,307 | ▼ 7% |
| Employees (FTE) | 179.8 | 172.2 | 165.2 | 175.8 | ▲ 10.6 |
By revenue, integrated DNA technologies ranks 4th of 4 companies with main activity “Vervaardiging van overige organische chemische basisproducten” in Flemish Brabant that publish figures (fiscal year 2025).
Key figures of integrated DNA technologies, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about integrated DNA technologies the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to integrated DNA technologies?
What happened at integrated DNA technologies in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 7.7 million (▲ 112% vs 2024). Source: NBB ↗
- Linda De Jesus stepped down as director. NBB
- Konstantin Fiedler became a director. NBB
- Christine Boge stepped down as director. NBB
- Linda De Jesus became a director. NBB
- Benny Vandecraen became a director. NBB
- Christine Boge became a director. NBB
- New establishment in Leuven. KBO
In short
From € 1.7 million profit in 2022 to € 7.7 million profit in 2025.
Paid € 4.6 million in corporate taxes since 2022.
Best year ever: 2025, with € 7.7 million profit.
Paid out € 19 million in dividends to the owners in total.
Management
Behind integrated DNA technologies are Benny Vandecraen and Konstantin Fiedler. The shares are held by Integrated DNA Technologies Inc (100%). It owns 100% of Integrated DNA Technologies UK Ltd, 100% of Integrated DNA Technologies Germany GmbH and 100% of Integrated DNA Technologies Spain SL itself.
Directors
According to the 2025 annual accounts
Benny Vandecraen
Director
since 2016
Konstantin Fiedler
Director
since 2025
Christine Boge
Director
since 2006 · until 2025
Linda De Jesus
Director
since 2023 · until 2025
Shareholders
Integrated DNA Technologies Inc
100%
Participations
Integrated DNA Technologies UK Ltd
100%
Integrated DNA Technologies Spain SL
100%
Establishments
Establishment units
Physical locations of this company
Interleuvenlaan 12A
3001 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Flemish Brabant
Same main activity (Vervaardiging van overige organische chemische basisproducten), 6 active companies in Flemish Brabant, largest first.
CHEVRON PHILLIPS CHEMICALS INTERNATIONAL
€ 1.5 billion revenue · 2025 · Machelen (Brab.)
€ 175.2 million revenue · 2025 · Machelen (Brab.)
€ 91.8 million revenue · 2025 · Tienen
€ 3.2 million gross margin · 2025 · Aarschot
€ 136,956 gross margin · 2025 · Tervuren
Details
- Company number
- 0473.291.407
- VAT number
- BE 0473.291.407
- Registered office
- Interleuvenlaan 12A, 3001 Leuven
- Names & denominations
- integrated DNA technologies
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 November 2000
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Vervaardiging van overige organische chemische basisproducten
Vervaardiging van andere organische chemische basisproducten
Vervaardiging van andere chemische producten, neg
Vervaardiging van overige chemische producten